Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 74.19 0.00%   SPY: 166.93 0.00%
Discuss Index Tracked By  


  Track the *RXSTM Index  

Stem Cell Stocks (*RXSTM)

  Stem Cell Ideas       Stem Cell Performance       Stem Cell Community  
 
Popular long ideas:
Popular short ideas:
Top dividend plays:
Pro favorites:
STEM, GERN, ASTM
GERN, CYTX, PSTI
None
CYTX, BTX, ATHX
 
Index Description: These companies have significant exposure to developing medical treatments using stem cells
     
Today:
1-month:
All-time:
-4.1%
+2.7%
+10.3%
vs S&P 500:
vs S&P 500:
vs S&P 500:
-4.1%
-4.7%
-10.5%
Data since: Jan-01-2008
 
Avg. Market Cap:
Avg. P/E Ratio:
Avg. Div Yield:
$119.6M
0.0
0.0%
     
591 members Tracking
Share this Index on Facebook
Share this Index on Twitter
 
                     
     
 
Chart View
1 week
 
1 month
 
3 months
 
6 months
 
All Time
 
 
 
 
 
 
 
   
     
 
Portfolio Detail
 
  Standard View     Performance View     Ideas & Research    
Click a column to sort | Scroll over columns for more information
 
 Ticker Last Trade  1-Week Change 1-Month Change  3-Month Change 6-Month Change 1-Year Change Links
OSIR $10.70 +4.5% -2.5% +52.6% +16.6% +68.2%  Spy OSIR, Post
ATHX $1.93 -9.0% -3.5% +26.1% +93.0% +38.9%  Spy ATHX, Post
CUR $1.45 +4.3% +30.6% +25.0% +39.4% +61.1%  Spy CUR, Post
STEM $1.90 +4.4% +16.2% +5.6% +1.1% +148.7%  Spy STEM, Post
CYTX $2.50 -10.7% +0.8% +4.6% -27.9% +16.3%  Spy CYTX, Post
KOOL $0.87 -8.4% +7.5% -4.4% +23.7% +7.2%  Spy KOOL, Post
NBS $0.56 -3.4% -9.6% -5.8% -13.7% +56.9%  Spy NBS, Post
BTX $3.92 -4.8% +3.4% -8.6% +11.4% -9.5%  Spy BTX, Post
PSTI $3.00 0.0% +0.7% -12.8% -9.6% +13.2%  Spy PSTI, Post
ISCO $0.28 -0.4% +10.8% -15.2% +53.9% -22.0%  Spy ISCO, Post
GERN $1.12 -4.3% +6.7% -21.1% -15.8% -20.0%  Spy GERN, Post
OPXA $1.67 -7.7% -1.2% -27.1% +297.6% +232.6%  Spy OPXA, Post
ASTM $0.58 -2.5% -17.4% -50.4% -49.1% -72.9%  Spy ASTM, Post
Is this index incomplete or incorrect?
Got an idea for a new Index?
 
Latest Portfolio Notes & Links
 
View: Headlines   |   Message Board   |   Portfolio Notes  
 
 
Pluristem Develops Point-of-Care Thawing Device for PLX Cells Linked by GlobeNewswire - October 04, 04:00AM - Reply
PSTI  
Athersys Reports on Progress in Phase 2 Study of MultiStem for Ischemic Stroke Linked by GlobeNewswire - October 02, 07:00AM - Reply
ATHX  
Cytori's Stem Cell Therapy for Burns Wins US Contract Linked by Bloomberg - September 28, 07:48AM - Reply
CYTX  
Osiris Therapeutics Regains Worldwide Rights to Prochymal and Chondrogen Linked by BusinessWire - September 28, 12:00AM - Reply
OSIR  
StemCells, Inc. Achieves Spinal Cord Injury Milestone With First Neural Stem Cell Transplant Into Patient With Sensory Function Below the Level of Injury Linked by GlobeNewswire - September 27, 09:52AM - Reply
STEM  
Pluristem Selects Fisher BioServices as Worldwide Dispatch Distributor of Its PLX Cell Therapies to Serve Global Clinical Studies Linked by GlobeNewswire - September 27, 04:00AM - Reply
PSTI  
Pluristem Announces Closing of Underwriters' Option to Purchase Additional Common Stock Linked by GlobeNewswire - September 24, 09:34AM - Reply
PSTI  
ThermoGenesis Reports Fourth Quarter and Full Year Fiscal 2012 Results Linked by GlobeNewswire - September 20, 04:00PM - Reply
KOOL  
ThermoGenesis Announces New Cord Blood Products Distribution Agreements Linked by GlobeNewswire - September 19, 12:38PM - Reply
KOOL  
Pluristem Announces Closing of Public Offering of Common Stock and Warrants to Purchase Common Stock Linked by GlobeNewswire - September 19, 10:03AM - Reply
PSTI  
Aastrom to Participate in Noble Financial Capital Markets' BioX Life Sciences Exposition Linked by GlobeNewswire - September 19, 09:00AM - Reply
ASTM  
Athersys CEO to Present on September 24, 2012 at the Noble Financial Life Sciences Exposition Linked by GlobeNewswire - September 18, 09:00AM - Reply
ATHX  
ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal 2012 on September 20, 2012 Linked by GlobeNewswire - September 14, 12:30PM - Reply
KOOL  
ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal 2012 on September 20, 2012 Linked by GlobeNewswire - September 14, 12:00PM - Reply
KOOL  
Today’s Market Winners and Losers Linked by 24/7 Wall St. - September 14, 10:55AM - Reply
CUR  BIOF  
24/7 Wall St. Closing Bell — September 13, 2012: Markets Get Behind FOMC Linked by 24/7 Wall St. - September 13, 04:04PM - Reply
INTC  BAC  PLL  PIR  AAPL  MSFT  AGN  ANF  LRN  PSTI  KUTV  ANR  BIOF  OPTT  
Today’s Market Winners and Losers Linked by 24/7 Wall St. - September 13, 11:32AM - Reply
CRBC  FMER  PSTI  SHLD  
Pluristem Announces Pricing of Public Offering of Common Stock and Warrants to Purchase Common Stock Linked by GlobeNewswire - September 13, 09:00AM - Reply
PSTI  
Pluristem Announces Proposed Public Offering of Common Stock and Warrants to Purchase Common Stock Linked by GlobeNewswire - September 12, 04:01PM - Reply
PSTI  
StemCells, Inc. to Present at Neurodegenerative Conditions Research and Development Conference Linked by GlobeNewswire - September 12, 09:00AM - Reply
STEM  
Page 1 ... 3 4 5 6 7 8 9 10 11 ... 49



Click to close X

Use portfolios to track tickers you're interested in. News related to your tickers will appear below the portfolio. Tickers in your portfolios will generate Alerts on your tickerspy Alerts page.

The Recent Tickers portfolio saves the tickers you've recently viewed on the site.

Click to close X

By matching similar portfolios, tickerspy helps members find institutional and individual investors with strategies similar to their own.

Click to close X

Portfolio performance for tickerspy member portfolios is calculated by equally weighting all of the stocks held in the portfolio.

Click to close X

Performance View offers a snapshot of how individual portfolio positions have performed since being added (or shorted) as well as a look at the individual stocks' performance over various time periods. In the case of "shorts," a decline in price will result in a positive gain.

Portfolio History offers a view of all current and past holdings in a portfolio.

Click to close X

Institutional Holdings Disclaimer

Pro portfolios track the top 15 quarterly holdings of more than 1,400 institutions. Comments in Pro portfolios show the institution's change in shares held for each company quarter over quarter.

Pro portfolio performance is based on institutions' top 15 holdings as disclosed in quarter-end filings with the SEC. Pro performance does not take into account additional holdings beyond the top 15 nor does it include positions that are not required to be disclosed by the SEC. As such, Pro portfolio performance should be considered an approximation and not a precise record of how an institution has performed over time.

tickerspy is not affiliated with any of the Pro investors profiled on our web site. The performance data and graph are estimates and do not represent an advertisement or endorsement by either tickerspy or the Pro investors.

Click to close X

To calculate "all-time" Pro performance, we combine all of the quarterly holdings reports for that Pro investor. The initial date used is the start date of the first quarterly holdings report we have in our database. Start dates vary based on the first quarterly holdings report we have for each Pro. Please see our Institutional Holdings Disclaimer (located at the bottom of this page) for more on how we calculate Pro portfolio performance estimates. tickerspy is not affiliated with any of Pro investors profiled on our web site.

Click to close X

Your primary portfolio will appear in other member’s Tracking Hubs when they track your performance. Your primary portfolio is also used in our Ideas & Research section, where your portfolio is compared with the portfolios of other members, and elsewhere on the site where other portfolio comparisons are made.

Note: Primary portfolios must contain at least five stocks of greater than $1 per share. If you have elected to make your primary portfolio private or if your portfolio is not eligible to be primary, it will not appear in the Ideas & Research section or on the front page.

Click to close X

Primary portfolio

Click to close X
Click the Alerts links in your portfolio to see news from the last 36 hours as well as data alerts displaying unusual price and volume action. You will also see Alerts related to the activity of other tickerspy members. To see more Alerts, visit your customized Alerts page. And for more Alerts info, visit our Alerts FAQ.
Click to close X
tickerspy Indexes use a "net asset value" calculation. The components are equally weighted at the inception of the Index (typically 1/1/2008) and over time as some stocks go up and others go down, the relative weights of the components shift accordingly.
Click to close X

We look at the recent net stock adds (people adding a stock to their portfolio minus people removing it) and compare against the company's previous history to identify those companies that are seeing the largest changes on a relative basis. Without the company history comparison, our most followed companies would likely be near the top of the list at all times. A value greater than one indicates a greater than normal number of adds over the last seven days, and a value less than one indicates a less than normal number of adds. If no value is shown, there was not enough activity to generate a value.

Click to close X

We look at the recent net stock shorts (people shorting it in their portfolios minus people covering their short) and compare against the company's previous history to identify those companies that are seeing the largest changes on a relative basis. A value less than -1 (for example -3.6) indicates a greater than normal number of shorts over the last seven days, and a value greater than -1 (for example -0.6) indicates a less than normal number of adds. If no value is shown, there was not enough activity to generate a value.

Click to close X

Thanks for helping us keep tickerspy Indexes accurate!

Let us know which tickers should be added or removed from the Stem Cell Stocks Index (*RXSTM).

Note: Our tickerspy research team will look at all recommendations but not all of them will be implemented. As a general rule, stocks with a market cap below $50 million will not be included.


Click to close X

Got an idea for an Index we don't have listed? Send it, and our research team will consider it for inclusion.

Note: Our tickerspy research team look at all recommendations but not all of them will be implemented. As a general rule, stocks with a market cap below $50 million will not be included.

Index Name

Tickers(separate with spaces or commas)

Additional comments